ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,843 | +7.9% | 30,000 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $2,635 | +22.5% | 30,000 | +50.0% | 0.01% | +20.0% |
| Q1 2023 | $2,151 | -10.8% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $2,412 | -99.9% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $2,037,000 | +46.2% | 20,000 | +32.8% | 0.01% | +50.0% |
| Q2 2022 | $1,393,000 | -50.1% | 15,060 | -37.4% | 0.00% | -42.9% |
| Q1 2022 | $2,791,000 | -3.8% | 24,060 | +10.1% | 0.01% | 0.0% |
| Q4 2021 | $2,901,000 | -12.8% | 21,860 | +2.8% | 0.01% | -22.2% |
| Q3 2021 | $3,328,000 | +17.8% | 21,270 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $2,825,000 | +3.7% | 21,270 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $2,725,000 | +44.6% | 21,270 | +88.7% | 0.01% | +28.6% |
| Q4 2020 | $1,885,000 | +4.5% | 11,270 | -4.7% | 0.01% | -12.5% |
| Q3 2020 | $1,804,000 | +18.8% | 11,830 | -15.5% | 0.01% | 0.0% |
| Q2 2019 | $1,518,000 | -20.8% | 14,000 | -48.3% | 0.01% | -27.3% |
| Q1 2019 | $1,916,000 | +42.1% | 27,100 | +22.3% | 0.01% | +22.2% |
| Q4 2018 | $1,348,000 | -29.6% | 22,150 | -18.3% | 0.01% | -18.2% |
| Q3 2018 | $1,916,000 | +508.3% | 27,100 | +464.6% | 0.01% | +450.0% |
| Q2 2018 | $315,000 | -76.1% | 4,800 | -76.9% | 0.00% | -77.8% |
| Q1 2018 | $1,319,000 | – | 20,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |